As a part of its restructuring exercise, Apollo Hospitals Enterprise on Wednesday said that it is divesting its front-end pharmacy business to Apollo Pharmacy for a lump sum cash consideration of Rs 527.8 crores. Apollo Pharmacy (APL) will be a wholly owned subsidiary of Apollo Medicals. The listed parent company, Apollo Hospitals Enterprise will hold 25.5% stake in Apollo Medicals (AMPL) and the remaining 74.5 % will be held by investors, including Jhelum Investment Fund, Hemendra Kothari and ENAM Securities. Specifically, Jhelum Investment Fund 1 would hold 19.9 %, Hemendra Kothari would hold 9.9 % and ENAM Securities would hold 44.7 % of the total share capital of AMPL.
— The Economic Times

L&L Partners advised Apollo Hospitals Enterprise Limited led by a team of partners Sundeep Dudeja and Vaibhav Kakkar, including managing associates Prashant Shah and Avisha Gupta, senior associate Sahil Arora; and associates Ritvika Thakur, Keshav Pareek and Bhavini Singh.

2018-11-14

Deal value: USD 75 million

This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.